Meeder Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $726K | Buy |
9,288
+1,148
| +14% | +$89.8K | 0.04% | 313 |
|
|
2025
Q1 | $590K | Sell |
8,140
-646
| -7% | -$46.8K | 0.04% | 327 |
|
|
2024
Q4 | $650K | Sell |
8,786
-329
| -4% | -$24.4K | 0.04% | 301 |
|
|
2024
Q3 | $602K | Sell |
9,115
-818
| -8% | -$54K | 0.04% | 303 |
|
|
2024
Q2 | $918K | Buy |
9,933
+2,813
| +40% | +$260K | 0.06% | 237 |
|
|
2024
Q1 | $680K | Buy |
7,120
+112
| +2% | +$10.7K | 0.07% | 241 |
|
|
2023
Q4 | $534K | Sell |
7,008
-1,170
| -14% | -$89.2K | 0.06% | 259 |
|
|
2023
Q3 | $567K | Sell |
8,178
-1,808
| -18% | -$125K | 0.07% | 233 |
|
|
2023
Q2 | $942K | Buy |
9,986
+514
| +5% | +$48.5K | 0.1% | 164 |
|
|
2023
Q1 | $784K | Buy |
9,472
+409
| +5% | +$33.8K | 0.09% | 200 |
|
|
2022
Q4 | $676K | Buy |
+9,063
| New | +$676K | 0.09% | 214 |
|